HomeCompareUBAZF vs CHD

UBAZF vs CHD: Dividend Comparison 2026

UBAZF yields 18.10% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UBAZF wins by $38.5K in total portfolio value
10 years
UBAZF
UBAZF
● Live price
18.10%
Share price
$11.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.9K
Annual income
$5,471.74
Full UBAZF calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — UBAZF vs CHD

📍 UBAZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUBAZFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UBAZF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UBAZF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBAZF
Annual income on $10K today (after 15% tax)
$1,538.46/yr
After 10yr DRIP, annual income (after tax)
$4,650.98/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, UBAZF beats the other by $3,543.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBAZF + CHD for your $10,000?

UBAZF: 50%CHD: 50%
100% CHD50/50100% UBAZF
Portfolio after 10yr
$45.7K
Annual income
$3,387.19/yr
Blended yield
7.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

UBAZF
No analyst data
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBAZF buys
0
CHD buys
11
PoliticianChamberTickerTypeAmountDate
Richard W. Allen🏢 House$CHD▼ Sell$15,001 - $50,0002025-10-10
Ro Khanna🏢 House$CHD▲ Buy$1,001 - $15,0002025-09-29
Lisa McClain🏢 House$CHD▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CHD▲ Buy$1,001 - $15,0002025-08-04
Ro Khanna🏢 House$CHD▲ Buy$1,000 - $15,0002025-08-04
Lisa McClain🏢 House$CHD▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$CHD▲ Buy$1,001 - $15,0002025-06-17
Jonathan Jackson🏢 House$CHD▼ Sell$15,001 - $50,0002025-05-14
Jonathan Jackson🏢 House$CHD▼ Sell$1,001 - $15,0002025-05-05
Jonathan Jackson🏢 House$CHD▲ Buy$1,001 - $15,0002025-04-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUBAZFCHD
Forward yield18.10%1.28%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$64.9K$26.4K
Annual income after 10y$5,471.74$1,302.64
Total dividends collected$35.0K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: UBAZF vs CHD ($10,000, DRIP)

YearUBAZF PortfolioUBAZF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$12,510$1,809.95$10,857$157.30+$1.7KUBAZF
2$15,502$2,116.12$11,814$196.49+$3.7KUBAZF
3$19,038$2,450.65$12,887$245.97+$6.2KUBAZF
4$23,183$2,812.73$14,097$308.68+$9.1KUBAZF
5$28,007$3,201.11$15,473$388.49+$12.5KUBAZF
6$33,581$3,614.20$17,046$490.55+$16.5KUBAZF
7$39,982$4,050.09$18,861$621.76+$21.1KUBAZF
8$47,288$4,506.60$20,973$791.47+$26.3KUBAZF
9$55,579$4,981.33$23,454$1,012.51+$32.1KUBAZF
10$64,941$5,471.74$26,398$1,302.64+$38.5KUBAZF

UBAZF vs CHD: Complete Analysis 2026

UBAZFStock

Uzabase, Inc. provides information infrastructure to support decision-making in business activities primarily in Japan and internationally. It operates SPEEDA, a business information platform that provides insights for business strategy development and market analysis, including global corporate data, industry reports, market data, M&A deals, and expert insights to financial institutions and general businesses; FORCAS, a B2B marketing platform; and NewsPicks, a social business media that offers economic and business news articles. The company also operates INITIAL, a startup information platform that provides one-stop source to general data, financing, investors, and business partners of startups, as well as articles on related topics; and AlphaDrive, a consulting business that supports corporate clients in relation to new business development, next generation human resource development, and revitalising organizations. In addition, it operates MIMIR, a network business; SPEEDA EDGE, a market intelligent platform that offers industry-driven insights, including emerging tech trends, disruptors, partnership deals, and custom research; and UB VENTURES, a venture capital business that focuses on financing seed to early-stage SaaS and media startups. Uzabase, Inc. was incorporated in 2008 and is headquartered in Tokyo, Japan.

Full UBAZF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this UBAZF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBAZF vs SCHDUBAZF vs JEPIUBAZF vs OUBAZF vs KOUBAZF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.